Immatics N.V. IMTX
$ 6.93
0.73%
Quarterly report 2022-Q2
added 08-09-2022
Country |
Germany |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Harpreet Singh |
Employees in the company |
230 |
Shares |
62.9 M |
Market Cap[1] |
$ 436 M |
EBITDA (LTM) |
$ -43 M |
P/E (LTM) |
-7.76 |
P/S (LTM) |
- |
EPS (LTM) |
-1.06 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.